Overview

Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries

Status:
Unknown status
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
Cesarean deliveries are the most common surgical procedure performed in the United States. A significant decrease in cesarean delivery associated maternal morbidity has been achieved with preoperative prophylactic single-dose cephalosporin, widely used before skin incision. Also, on laboring patients and/or with rupture of membranes, several studies suggest that adding azithromycin to standard cephalosporin prophylaxis is cost-effective and reduces overall rates of endometritis, wound infection, readmission, use of antibiotics and serious maternal events. Azithromycin has effective coverage against Ureaplasma, associated with increased rates of endometritis. Although two-drug regimen has been suggested for laboring and/or patients that undergo cesarean delivery, no studies have investigated the potential benefits of two-drug regimen in non-laboring patients.
Phase:
Phase 2
Details
Lead Sponsor:
RWJ Barnabas Health at Jersey City Medical Center
Treatments:
Azithromycin
Cefotaxime
Cefoxitin